Guidelines for the risk assessment of new synthetic drugs
| Corporate συγγραφέας: | European Commission. |
|---|---|
| Μορφή: | Βιβλίο |
| Γλώσσα: | English |
| Στοιχεία έκδοσης: |
Luxembourg:
Office for Official Publications of the European Communities,
1999
|
| Ταξινομικός αριθμός: |
KET 615.31 GUI |
| Θέματα: | |
| Ετικέτες: |
Προσθήκη ετικέτας
Δεν υπάρχουν, Καταχωρήστε ετικέτα πρώτοι!
|
| LEADER | 00657nam a2200181 4500 | ||
|---|---|---|---|
| 001 | 1/22901 | ||
| 008 | 050526s1999 lu a n00010 eng | ||
| 020 | |a 9291680613 | ||
| 035 | |l 24374 | ||
| 040 | |a GR-PeUP | ||
| 082 | 0 | 0 | |a KET 615.31 GUI |
| 245 | 0 | 4 | |a Guidelines for the risk assessment of new synthetic drugs |
| 260 | |a Luxembourg: |b Office for Official Publications of the European Communities, |c 1999 | ||
| 300 | |a 33 σ.: |b εικ.; |c 21 εκ. | ||
| 650 | 4 | |a Designer Drugs |x Adverse effects |z Europe. | |
| 650 | 4 | |a Drug Evaluation |x Standards |z Europe. | |
| 710 | 2 | 0 | |a European Commission. |
| 852 | |a INST |b UNIPILB |c KET |e 20051110 |h KET 615.31 GUI |p 00146759 |q 00146759 |t LOAN |y 0 |4 1 | ||